Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
A prospective study was carried out to evaluate the role of troponin I in risk stratification of non-ST-elevation myocardial infarction in 40 smoker and 40 non-smoker patients. The troponin I was significantly higher (p<0.001) in smokers (35.5 ± 5.22 ng/mL) than non-smoker (0.27 ± 0.01 ng/mL). Th...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Bangladesh Pharmacological Society,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_954ce69b2bc9404f919d290cb7b1ed92 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Iram Shahriar |e author |
700 | 1 | 0 | |a Shahina Sobhan |e author |
700 | 1 | 0 | |a Ziarrat Islam |e author |
245 | 0 | 0 | |a Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers |
260 | |b Bangladesh Pharmacological Society, |c 2011-01-01T00:00:00Z. | ||
500 | |a 10.3329/bjp.v5i2.6666 | ||
500 | |a 1991-0088 | ||
520 | |a A prospective study was carried out to evaluate the role of troponin I in risk stratification of non-ST-elevation myocardial infarction in 40 smoker and 40 non-smoker patients. The troponin I was significantly higher (p<0.001) in smokers (35.5 ± 5.22 ng/mL) than non-smoker (0.27 ± 0.01 ng/mL). The duration of hospital stay was longer in Group I (106.6 ± 2.36 hour) than in Group II (49.20 ± 1.01 hour). The major adverse cardiac event was higher in smoker (71.79%) compared to non-smokers (10.8%). So, it may be concluded that higher value of troponin I with history of smoking in non-ST-elevation myocardial infarction may be considered as 'high risk group' patients. | ||
546 | |a EN | ||
690 | |a Myocardial infarction | ||
690 | |a Troponin I | ||
690 | |a Smoker | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Bangladesh Journal of Pharmacology, Vol 5, Iss 2 (2011) | |
787 | 0 | |n https://www.banglajol.info/index.php/BJP/article/view/6666 | |
787 | 0 | |n https://doaj.org/toc/1991-0088 | |
856 | 4 | 1 | |u https://doaj.org/article/954ce69b2bc9404f919d290cb7b1ed92 |z Connect to this object online. |